|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.60 USD | +0.16% |
|
-2.21% | -27.79% |
| 05-16 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.16% | -2.21% | -1.86% | -3.74% | -27.79% | +11.90% | +42.40% | +45.24% | +151.58% | 1.09B | |
| +0.82% | -2.04% | +3.88% | +21.50% | +2.95% | +43.56% | +141.73% | +399.61% | +1,414.07% | 980B | |
| +1.06% | -2.01% | -1.46% | -1.91% | +11.58% | +52.60% | +39.43% | +41.13% | +98.28% | 550B | |
| +6.10% | +3.66% | +6.49% | +12.09% | +0.53% | +25.00% | +67.16% | +100.26% | +280.36% | 382B | |
| -0.06% | -3.09% | -3.21% | +6.28% | -2.56% | +23.33% | +16.78% | -8.41% | +30.00% | 316B | |
| +0.42% | +0.68% | -4.50% | -3.29% | -3.63% | +27.54% | +14.57% | +59.16% | +241.91% | 272B | |
| +1.67% | +0.05% | +0.69% | +3.58% | +9.74% | +26.50% | +33.56% | +40.20% | +56.51% | 268B | |
| +2.39% | +5.02% | +3.79% | +27.48% | -7.78% | -33.44% | -44.76% | +16.87% | +72.53% | 199B | |
| +1.91% | -2.12% | +1.12% | -1.91% | +4.82% | +25.93% | +49.39% | +43.01% | +129.02% | 182B | |
| +0.82% | +0.09% | -7.41% | -9.41% | +1.36% | +17.16% | +59.28% | +85.55% | +50.89% | 154B | |
| -0.65% | -3.75% | -3.38% | -6.52% | +0.50% | +4.14% | -35.39% | -36.82% | -27.40% | 144B | |
| +3.16% | +3.01% | +6.78% | +2.83% | +2.35% | +4.61% | +33.27% | +145.67% | +444.47% | 115B | |
| +1.19% | -3.09% | -8.34% | -4.39% | +1.04% | +16.16% | -16.54% | -17.35% | -24.63% | 110B | |
| -2.23% | -5.35% | -6.51% | -6.81% | -12.37% | -12.89% | -26.05% | -17.83% | +3.51% | 102B | |
| -0.05% | -1.71% | +0.50% | -0.65% | +5.48% | +37.17% | +41.61% | +10.38% | +8.46% | 101B | |
| -0.37% | +0.97% | -4.01% | -13.04% | -8.75% | +4.63% | +74.77% | +82.53% | +519.09% | 77.05B | |
| +0.83% | -2.11% | -3.96% | -13.75% | +2.90% | +16.02% | +8.55% | +36.04% | +11.02% | 48.34B | |
| +1.94% | +1.79% | -4.06% | -10.48% | -17.14% | -4.64% | +6.38% | -28.99% | +239.44% | 47.32B | |
| +0.90% | +5.15% | -0.86% | -0.74% | +3.16% | +45.53% | -24.40% | -25.58% | -58.43% | 42.64B | |
| -0.72% | -1.04% | -3.55% | -9.30% | -11.53% | -13.65% | +2.03% | - | - | 39.01B | |
| Average | +0.91% | -1.56% | -1.49% | -0.61% | -2.26% | +15.86% | +24.19% | +51.09% | +191.62% | 206.5B | |
| Weighted average by Cap. | +1.26% | -2.95% | +0.28% | +6.28% | +1.91% | +27.00% | +52.71% | +125.98% | +434.54% |
- Stock Market
- Stocks
- COLL Stock
- Sector Collegium Pharmaceutical, Inc.
Select your edition
All financial news and data tailored to specific country editions
